Renown Offers New closing device for arterial puncture|
RENO, Nev. (March 25, 2009) – Renown Health is the first in the region to use a new closure device to stop bleeding and help minimize pain during the final step of cardiovascular procedures (procedures used to either diagnose or treat diseased vessels) like angioplasty. Manufactured by AccessClosure, Inc., the Mynx™ Vascular Closure Device (VCD) represents an alternative approach to vascular closure.
Renown Health is the first healthcare network to bring the new technology to the region. Michael Newmark, M.D., of Sierra Nevada Cardiology Associates, successfully used the device at Renown Regional Medical Center, Tuesday, March 10. The procedure was done in the Renown Regional Medical Center catheterization laboratory with experienced registered nurses and radiology technicians assisting.
Unlike previous vascular closure devices that use metal or animal-based implants to close the small hole in the artery left after cardiovascular procedures, the Mynx uses a soft, bio-absorbable, sponge-like material to seal the hole. The sealant material is called polyethylene glycol (PEG) and has been used safely for more than a decade in a range of medical products including gel caps and eye drops.
When deployed, the sealant is gently place over the small hole in the artery initially created to gain access for the procedure. The sealant immediately expands to 3-4 times its original size by rapidly absorbing the blood and fluids around the puncture site, which quickly closes the hole and stops the bleeding. The sealant then dissolves naturally within 30 days, leaving nothing behind but a healed artery.
“It is adds more options for completing the procedure” said Devang Desai, M.D., another cardiologist with Sierra Nevada Cardiology Associates, who helped bring the technology to the region. “Innovative tools and techniques like these make a big difference in patient care and comfort.”
There are two main methods for closing the femoral artery after cardiovascular procedures. The first is manual compression, which entails up to 30 minutes of manual pressure or clamps applied directly to the access site. Manual compression is often painful and followed by several hours of bed rest in a hospital recovery room. The second option is vascular closure devices like the Mynx™ that is frequently preferred by physicians because patients generally stop bleeding faster and typically can leave the hospital sooner.
However, despite the benefits of VCDs, many patients find that the closure is the most painful part of the procedure and as a result, they often require additional pain medication. The Mynx eliminates any tugging or cinching of the artery during insertion and placement. Also, the gentle deployment of the sealant on top of the artery, rather than inside, significantly reduces pain and makes the procedure more comfortable for the patient.
About AccessClosure, Inc.
Founded in 2002, AccessClosure, Inc. is a privately-held medical device company pioneering innovative access site management products designed to provide a patient-friendly, seamless and dependable vascular closure experience.
The Mynx Vascular Closure Device is based on a conformable, water-soluble PEG sealant that instantly expands in the tissue tract by rapidly absorbing blood and subcutaneous fluids. The sealant then dissolves within 30 days, leaving nothing behind but a healed artery. The Mynx received FDA approval in May 2007. For more information visit www.accessclosure.com.